FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to cardiology. In patients, identify risk factors: hyperhomocysteinemia, the fact of smoking, the presence of stenoses in two or more coronary arteries, narrowing the lumen of the vessel by 75 % or more. Then calculate the risk of developing adverse cardiovascular events P according to the original mathematical formula. With a P value is 0.62 or more, the risk of developing adverse cardiovascular events is assessed as high. At a P value is less than 0.62, the risk is assessed as low.
EFFECT: method allows to predict the onset of adverse cardiovascular events in patients with coronary heart disease on the background of metabolic syndrome without insulin resistance within one year after endovascular myocardial revascularization by quantifying the most sensitive predictors of an unfavorable course of the disease.
1 cl, 1 dwg, 3 tbl, 2 ex
